ArticleBiomedicines2022

Efficacy and Safety of Cabozantinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Cohort Study.

Koji Iinuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.